Computational Chemist, Target Druggability and Structure-Based Design

Schrödinger; New York, Cambridge, San Diego, Portland (NY, MA, CA, OR); On-site; USD 100,000 - 180,000; Full time

Benefits offered by this job

Healthcare

Dental & Vision

401k

Pre-tax commuter benefits

Flexible schedule

Parental leave

Vacation time

Company events

Job summary

Schrödinger in New York, NY is seeking a Computational Chemist to join the Therapeutics Group and drive target druggability and structure-based design. You’ll combine molecular modelling, structural biology, and lead optimization to advance active drug discovery programs.

The role requires a PhD in a relevant field, experience in structure-based drug design, and collaboration across disciplines. We offer competitive compensation, equity, benefits, and a dynamic, collaborative work environment.

Qualifications

• PhD in Computational Chemistry, Structural Biology, or a related discipline.
• Experience in structure-based drug design and interpretation of protein structures with ligands.
• Postdoctoral experience and/or at least one year in industry preferred.

Responsibilities

• Support active drug discovery projects as a computational chemist/modeler.
• Contribute to target selection by integrating structural, computational, biophysical and biological evidence.
• Collaborate with cross-functional experts to develop strategies for promising targets.
• Work with internal software teams to improve Schrödinger's drug discovery technologies.
• Share knowledge with Schrödinger Therapeutic Group (STG).

Skills

Molecular modelling

Structural biology

Lead optimization

Virtual ligand screening

Generative structure prediction

Cryptic pockets

Cross-functional collaboration

Education

PhD in Computational Chemistry, Structural Biology, or related

Job description

Computational Chemist, Target Druggability and Structure-Based Design

Schrödinger seeks a Computational Chemist(Target Druggability and Structure-Based Drug Design) to join us in our mission to transform the discovery of therapeutics!

As a member of the Schrödinger Therapeutics Group (STG), you’ll join a team of over 60 scientists that includes designers, modelers, computational chemists, medicinal chemists, crystallographers, biochemists, and biologists with experience working on all common target classes and therapeutic areas. The group is supported by more than 100 software developers and engineers, as well as a large-scale computer infrastructure.

Who will love this job:

• A structure-based drug designer with deep training in molecular modelling, with an emphasis on the following areas: structural biology, computationally-driven lead optimization, virtual ligand screening, generative structure prediction, or cryptic pocket identification.
• A scientist trained cross-functionally, with experience in both computational chemistry and experimental structural biology or experimental hit-finding environments
• A team player who enjoys working in interdisciplinary environments and has excellent communication skills

What you’ll do:

• Support active drug discovery projects as a computational chemist/modeler
• Contribute to new-target selection by integrating structural, computational, biophysical, and biological evidence into concise target-tractability assessments, identifying key uncertainties and proposing experiments or calculations that could resolve them.
• Partner with cross-functional experts to develop strategies for promising targets, including approaches to investigate alternative conformations or potential transient binding sites.
• Work closely with the internal software development teams to improve Schrödinger’s drug discovery technologies.
• Share knowledge with the greater Schrödinger Therapeutic Group (STG)

What you should have:

• PhD in Computational Chemistry, Structural Biology, or a related discipline
• Experience in structure-based drug design and the ability to critically interpret protein structures in the context of ligand binding, drawing on modern computational and experimental approaches for structure prediction and cryptic pocket identification
• Postdoctoral experience and/or at least one year of industry experience preferred

Pay and perks:

Schrödinger understands it’s people that make a company great. Because of this, we’re prepared to offer a competitive salary, equity-based compensation, and a wide range of benefits that include healthcare (with dental and vision), a 401k, pre-tax commuter benefits, a flexible work schedule, and a parental leave program. We have a company culture that is relaxed, but engaged, and over a month of paid vacation time. Our Office Management team also plans a myriad of fun company-wide events. New York is home to our largest office, but we have teams all over the world. Schrödinger is honored to have been included in Crain's New York Best Places to Work, BuiltIn's NYC Best Place to Work, and Newsweek's list of America's 100 Most Loved Workplaces.

Estimated base salary range: $100,000 - $180,000. Actual compensation package is dependent on a number of factors, including, for example, experience, education, degrees held, market data, and business needs. If you have any questions regarding the compensation for this role, do not hesitate to reach out to a member of our Strategic Growth team.

As an equal opportunity employer, Schrödinger hires outstanding individuals into every position in the company. People who work with us have a high degree of engagement, a commitment to working effectively in teams, and a passion for the company's mission. We place the highest value on creating a safe environment where our employees can grow and contribute, and refuse to discriminate on the basis of race, color, religious belief, sex, age, disability, national origin, alienage or citizenship status, marital status, partnership status, caregiver status, sexual and reproductive health decisions, gender identity or expression, sexual orientation, or any other protected characteristic. To us, "diversity" isn't just a buzzword, but an important element of our core principles and key business practices. We believe that diverse companies innovate better and think more creatively than homogenous ones because they take into account a wide range of viewpoints. For us, greater diversity doesn't mean better headlines or public images - it means increased adaptability and profitability.

As set forth in Schrödinger’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection.As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measurethe effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categoriesis as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.